✦ LIBER ✦

Clinical Strategies to Achieve an Early and Successful Response to Tyrosine Kinase Inhibitor Therapy

✍ Scribed by Timothy Hughes; Andreas Hochhaus

Book ID: 117822136
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 375 KB
Volume: 46
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2009.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9087 POSTER Clinical Responses to EGFR-t

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

✍ Watanabe, S.; Saida, Y.; Ichikawa, K.; Koshio, J.; Baba, J.; Miura, S.; Tanaka, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Early response to high-dose methotrexate

Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response

✍ Yu Ri Kim, Se Hoon Kim, Jong Hee Chang, Chang-Ok Suh, Soo-Jeong Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 380 KB

The Potential Clinical and Economic Outc

The Potential Clinical and Economic Outcomes of Pharmacogenomic Approaches to EGFR-Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Activating and resistance mutations of E

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Response to Tyrosine Kinase Inhibitor Th

Response to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myelogenous Leukemia Relapsing in Chronic and Advanced Phase Following Allogeneic Hematopoietic Stem Cell Transplantation

✍ Matthew P. Wright; John D. Shepherd; Michael J. Barnett; Stephen H. Nantel; Heat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 201 KB

MP57-14 CHANGE IN PLATELET COUNT AS A PR

MP57-14 CHANGE IN PLATELET COUNT AS A PROGNOSTIC INDICATOR FOR RESPONSE TO NEOADJUVANT TYROSINE KINASE INHIBITOR THERAPY IN METASTATIC RENAL CELL CARCINOMA

✍ Lee, Hak; Patel, Nishant; Kopp, Ryan; Liss, Michael; Mehrazin, Reza; Jabaji, Ram 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB